Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGG-18: Elbasvir/Grazoprevir in HCV GT1b
NCT03496233Phase 3Completed
- Sponsor
- Policlinico Paolo Giaccone
- Start
- Sep 2018
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of elbasvir + grazoprevir in hepatitis C (HCV), sponsored by Policlinico Paolo Giaccone. Started Sep 2018; status: completed.
02
Drugs
elbasvir + grazoprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03496233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03496233.